Company Overview
| Stock Name | Pashun Int'l |
|---|---|
| Stock Code | 00574 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 我們是中國西南部的綜合醫藥公司,上游合併業務模式涵蓋醫藥行業價值鏈的主要階段,主要營運醫藥分銷、自營零售藥房及製藥三個業務分部。 |
| Listing Date | 2015-06-19 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港灣仔港灣道6–8號瑞安中心26樓2601–2603室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | pashun.com.cn |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 1.22 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | RMB 0.001 / shares |
| Offer Period | 2015-06-09 to 2015-06-12 |
| Global Offering Shares | 250,000,000 shares |
| HK Public Offer Shares (Initial) | 25,000,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 225,000,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 1,000,000,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 305,000,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 60.1M |
| Est. Threshold | HK$ 9.69B |
| Analysis Result | HK market cap below threshold, need +16039% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約人民幣46.1百萬元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | ~HK$ 50,600,000 |
| Listing Expenses / Funds Raised | ~16.59% |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2012 | 2013 | 2014 |
|---|---|---|---|
| Profit for the year | 9,308 | 63,069 | 46,129 |
Balance Sheet
| Item | 2012 | 2013 | 2014 |
|---|---|---|---|
| Cash and cash equivalents | 39,227 | 65,375 | 67,059 |
| Trade and bills receivables | 292,367 | 350,609 | 363,799 |
| Inventories | 67,876 | 58,817 | 69,128 |
| Total current assets | 432,646 | 532,769 | 575,181 |
| Total assets | 505,644 | 687,189 | 713,992 |
| Total current liabilities | 370,055 | 484,500 | 468,601 |
| Total liabilities | 433,029 | 546,109 | 532,712 |
| Total equity | 72,615 | 141,080 | 181,280 |
| Equity attributable to owners | 71,738 | 140,204 | 180,219 |
| Interest-bearing borrowings | 24,000 | 75,000 | 50,000 |
Cash Flow Statement
| Item | 2012 | 2013 | 2014 |
|---|---|---|---|
| Net cash from operating activities | -42,242 | 92,225 | 48,664 |
| Net cash from investing activities | -2,698 | -105,599 | -16,294 |
| Net cash from financing activities | 34,067 | 39,935 | -30,933 |
| Net increase in cash | -10,873 | 26,561 | 1,437 |
| Depreciation of PP&E | 2,874 | 3,771 | 9,368 |
| Amortisation of intangible assets | 455 | 522 | 619 |
| Purchase of PP&E | -3,870 | -10,523 | -19,833 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 1.42 |
|---|---|
| First Day Open | HK$ 1.2 |
| First Day Change | 16.39% |
| First Day Volume | 206913000.0 |
| First Day Turnover | 274725000.0 |
| Use of Proceeds | 1、約48.6%,或123.6百萬港元,預計用作公司于成都的計劃物流中心,其中約49.5%,或60.0百萬港元,預計用作建設設施及裝修租賃物業,及約50.5%,或61.3百萬港元,預計用作購置及安裝設備及軟件;
2、約46.6%,或118.5百萬港元,預計主要用作收購或成立自營零售藥店;
3、約4.8%,或12.2百萬港元,預計用作撥支營運資金及一般企業用途。 |
Underwriting Syndicate
Sole Sponsor (1)
CHINA EVERBRIGHT CAPITAL LIMITED CE ACE409
Overall Coordinators (1)
CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536
Joint Bookrunners (1)
CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536
Joint Lead Managers (1)
CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 陳燕飛 | — |
| Company Secretary | 雷美嘉 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 陳先生及嘉寶上市後持股約48.80%;Li Ho Tan先生約23.05%;晉鼎及Cheung Chi Mang先生約19.30%。 |
|---|




